Metformin-associated lactic acidosis

BMJ Case Rep. 2021 Jul 8;14(7):e239154. doi: 10.1136/bcr-2020-239154.

Abstract

A 58-year-old female with known type 2 diabetes mellitus continued to take her usual medications, including metformin, an ACE inhibitor and a non-steroidal anti-inflammatory drug, while suffering from diarrhoea and vomiting. On presentation to the emergency department, she was found to have a profound lactic acidosis, cardiovascular instability and acute kidney injury. Despite a pH of 6.6, lactate of 14 mmol/L and a brief asystolic cardiac arrest, supportive treatment and the use of renal replacement therapy resulted in rapid improvement in her acid-base abnormalities and haemodynamic parameters. Metformin-associated lactic acidosis is a rare but life-threatening complication of diabetes management. Patient education and awareness amongst clinicians are paramount in the prevention and treatment of this condition.

Keywords: adult intensive care; diabetes; dialysis; drugs: endocrine system; unwanted effects / adverse reactions.

Publication types

  • Case Reports

MeSH terms

  • Acidosis, Lactic* / chemically induced
  • Acidosis, Lactic* / therapy
  • Acute Kidney Injury* / chemically induced
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Female
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Metformin* / adverse effects
  • Middle Aged

Substances

  • Hypoglycemic Agents
  • Metformin